JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Devchand, P. R.
Right arrow Articles by Wahli, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Devchand, P. R.
Right arrow Articles by Wahli, W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 33, 23341-23348, August 13, 1999

Chemical Probes That Differentially Modulate Peroxisome Proliferator-activated Receptor alpha  and BLTR, Nuclear and Cell Surface Receptors for Leukotriene B4

Pallavi R. DevchandDagger , Abdelmadjid K. HihiDagger , Mai PerroudDagger , Wolf-Dieter D. Schleuning, Bruce M. Spiegelmanparallel , and Walter WahliDagger

From the Dagger  Institut de Biologie Animale, Bâtiment de Biologie, Université de Lausanne, CH-1015 Lausanne, Switzerland, the parallel  Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, and  Schering AG, Institute for Cell and Molecular Biology, Berlin D-1000, Germany

Peroxisome proliferator-activated receptor alpha  (PPARalpha )is a nuclear receptor for various fatty acids, eicosanoids, and hypolipidemic drugs. In the presence of ligand, this transcription factor increases expression of target genes that are primarily associated with lipid homeostasis. We have previously reported PPARalpha as a nuclear receptor of the inflammatory mediator leukotriene B4 (LTB4) and demonstrated an anti-inflammatory function for PPARalpha in vivo (Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., and Wahli, W. (1996) Nature 384, 39-43). LTB4 also has a cell surface receptor (BLTR) that mediates proinflammatory events, such as chemotaxis and chemokinesis (Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., and Shimizu, T. (1997) Nature 387, 620-624). In this study, we report on chemical probes that differentially modulate activity of these two LTB4 receptors. The compounds selected were originally characterized as synthetic BLTR effectors, both agonists and antagonists. Here, we evaluate the compounds as effectors of the three PPAR isotypes (alpha , beta , and gamma ) by transient transfection assays and also determine whether the compounds are ligands for these nuclear receptors by coactivator-dependent receptor ligand interaction assay, a semifunctional in vitro assay. Because the compounds are PPARalpha selective, we further analyze their potency in a biological assay for the PPARalpha -mediated activity of lipid accumulation. These chemical probes will prove invaluable in dissecting processes that involve nuclear and cell surface LTB4 receptors and also aid in drug discovery programs.


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Circ. Res.Home page
P. R. Devchand, O. Ziouzenkova, and J. Plutzky
Oxidative Stress and Peroxisome Proliferator-Activated Receptors: Reversing the Curse?
Circ. Res., December 10, 2004; 95(12): 1137 - 1139.
[Full Text] [PDF]


Home page
J. Immunol.Home page
A. J. Schottelius, C. Giesen, K. Asadullah, I. M. Fierro, S. P. Colgan, J. Bauman, W. Guilford, H. D. Perez, and J. F. Parkinson
An Aspirin-Triggered Lipoxin A4 Stable Analog Displays a Unique Topical Anti-Inflammatory Profile
J. Immunol., December 15, 2002; 169(12): 7063 - 7070.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Kilfeather
5-Lipoxygenase Inhibitors for the Treatment of COPD*
Chest, May 1, 2002; 121(5_suppl): 197S - 200S.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-H. Woo, H.-J. You, S.-H. Cho, Y.-W. Eom, J.-S. Chun, Y.-J. Yoo, and J.-H. Kim
Leukotriene B4 Stimulates Rac-ERK Cascade to Generate Reactive Oxygen Species That Mediates Chemotaxis
J. Biol. Chem., March 1, 2002; 277(10): 8572 - 8578.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. L. Goulet, R. C. Griffiths, P. Ruiz, R. B. Mannon, P. Flannery, J. L. Platt, B. H. Koller, and T. M. Coffman
Deficiency of 5-Lipoxygenase Accelerates Renal Allograft Rejection in Mice
J. Immunol., December 1, 2001; 167(11): 6631 - 6636.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
T. Yokomizo, K. Kato, K. Terawaki, T. Izumi, and T. Shimizu
A Second Leukotriene B4 Receptor, BLT2: A New Therapeutic Target in Inflammation and Immunological Disorders
J. Exp. Med., August 8, 2000; 192(3): 421 - 432.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.